GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings50 positions
SHIRE PLC | 4.6M | $794.2M | 7.7% | $173.00 | — | 1 qtr | First report 0 |
FMC CORP | 8.9M | $659.2M | 6.4% | $52.29 | 0.00% | 1 qtr | First report 0 |
IQVIA HLDGS INC | 5.4M | $623M | 6.0% | $113.91 | 0.00% | 1 qtr | First report 0 |
HCA HEALTHCARE INC | 4.9M | $609.6M | 5.9% | $115.24 | 0.00% | 1 qtr | First report 0 |
CVS HEALTH CORP | 8.5M | $556.3M | 5.4% | $51.03 | 0.00% | 1 qtr | First report 0 |
THE CIGNA GROUP | 2.7M | $516.3M | 5.0% | $170.77 | 0.00% | 1 qtr | First report 0 |
MCKESSON CORP | 4.5M | $499.4M | 4.8% | $104.44 | 0.00% | 1 qtr | First report 0 |
DXC TECHNOLOGY CO | 9.2M | $489.9M | 4.7% | $51.13 | 0.00% | 1 qtr | First report 0 |
ALPHABET INC | 446,051 | $466.1M | 4.5% | $51.94 | 0.00% | 1 qtr | First report 0 |
DOWDUPONT INC COM | 8.6M | $460.8M | 4.5% | — | — | 1 qtr | First report 0 |
FIRST DATA CORP NEW | 25.8M | $435.9M | 4.2% | — | — | 1 qtr | First report 0 |
HOLOGIC INC | 9.9M | $407.5M | 3.9% | $40.45 | 0.00% | 1 qtr | First report 0 |
TENET HEALTHCARE CORP | 17.9M | $306.7M | 3.0% | $17.14 | 0.00% | 1 qtr | First report 0 |
THERMO FISHER SCIENTIFIC INC | 1.2M | $263.4M | 2.6% | $219.16 | 0.00% | 1 qtr | First report 0 |
ELEVANCE HEALTH INC | 872,433 | $229.1M | 2.2% | $235.91 | 0.00% | 1 qtr | First report 0 |
UNIVERSAL HLTH SVCS INC | 2M | $228.8M | 2.2% | $112.51 | 0.00% | 1 qtr | First report 0 |
EBAY INC. | 7.2M | $201.9M | 2.0% | $25.13 | 0.00% | 1 qtr | First report 0 |
WILLIAMS COS INC | 8.8M | $194.3M | 1.9% | $14.57 | 0.00% | 1 qtr | First report 0 |
CBS CORP NEW | 4.1M | $178.6M | 1.7% | — | — | 1 qtr | First report 0 |
NVENT ELECTRIC PLC | 6.7M | $149.5M | 1.4% | $18.95 | 0.00% | 1 qtr | First report 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $10.3B across 50 positions as of Q4 2018. Top holdings: SHPG (7.7%), FMC (6.4%), IQV (6.0%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
First quarter we have for this fund: 50 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $10.3B across 50 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR